Status: Recruiting
Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA)
This is a pragmatic pilot trial designed to compare and evaluate the efficacy, safety, and cost-effectiveness of pharmacopuncture treatment versus a control group in aromatase inhibitor-induced arthralgia patients with breast cancer.
Participants needed: 30
Trial details
Age: 19-75Biological sex: FemaleType: InterventionalSponsor: Ilsan Cha hospitalUpdated: Sep 11, 2026Locations: 3
Eligibility criteria
Women aged 19 to 75 years [+6]
Patients with Stage IV (metastatic) breast cancer. [+10]